Document is current
Any future updates will be listed below
-
Authors
Sihto, Harri https://orcid.org/0000-0001-5265-5509
Giger, Olivier
Toivanen, Kirsi https://orcid.org/0000-0001-9287-3682
Salmikangas, Sami https://orcid.org/0000-0002-6264-4587
Vesterinen, Tiina https://orcid.org/0000-0003-2997-0337
Sampo, Mika https://orcid.org/0000-0001-9454-4495
Böhling, Tom https://orcid.org/0000-0001-8903-3690
-
Funding
Funding for this research was provided by:
Medicinska Understödsföreningen Liv och Hälsa (4708936)
Finska Läkaresällskapet (4709747)
Sigrid Juséliuksen Säätiö (4706829)
Syöpäsäätiö (47019194)
Academy of Finland (1354802)
University of Helsinki
- License Information
-
More Information
Article History
Received: 2 May 2025
Revised: 28 May 2025
Accepted: 7 June 2025
First Online: 18 June 2025
Declarations
:
: Harri Sihto owns stocks of Sartar Therapeutics Ltd. No other conflicts of interest declared.
